Jinding Pharmaceutical's half annual net profit in 2022 decreased by 56.05% year -on -year year -on -year

On August 10, Jinding Pharmaceutical (Code: 839633.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 57.8249 million yuan, a year-on-year decrease of 4.36%, net profit of 5.2484 million yuan, a year-on-year decrease of 56.05%, and the basic earnings per share were 0.2600 yuan.

The company's industry is chemical pharmaceutical.

During the company's reporting period, the total assets at the end of the period were 81.559 million yuan, the operating profit was 5.2814 million yuan, the accounts receivable were 5.9576 million yuan, and the net cash flow generated by operating activities was -8.632 million yuan.The cash was 65.8765 million yuan.

Jinding Pharmaceutical, the company's full name Anhui Jinding Pharmaceutical Co., Ltd., was established on August 17, 2007. It is currently general manager Jiang Aiping. The main business is the production and sales of pharmaceutical intermediates.

- END -